Comprehensive Shielding System Enhances Radiation Protection for Structural Heart Procedures

• Published in: Journal of the Society for Cardiovascular Angiography & Interventions Vol. 3; no. 1; p. 101110
• Main Authors: Rizik, David G, Burke, Robert F, Klassen, Sabrina R, Nigoghosian, Ariana M, Riley, Robert D, Gosselin, Kevin P, Goldstein, James A
• Format: Journal Article
• Language: English
• Published: United States 01.01.2024
• Subjects: radiation safety; occupational health; occupational hazard
• ISSN: 2772-9303; 2772-9303
• DOI: 10.1016/j.jscai.2023.101110

This study of radiation exposure (RE) to physicians performing structural heart procedures evaluated the efficacy of a novel comprehensive radiation shield compared to those of traditional shielding methods. A novel comprehensive shielding system (Protego, Image Diagnostics Inc) has been documented to provide superior RE protection during coronary procedures compared to that provided by a standard "drop down" shield. The purpose of this study was to assess the efficacy of this shield in transcatheter aortic valve replacement (TAVR) procedures, which are associated with disproportionate RE to operators. This single-center, 2-group cohort, observational analysis compared RE to the primary physician operator performing TAVR using the Protego shield (n = 25) with that using a standard drop-down shield with personal leaded apparel (n = 25). RE was measured at both thyroid and waist levels with a real-time dosimetry system (RaySafe i3, RaySafe) and was calculated on a mean per case basis. Data were collected on additional procedural parameters, including access site(s) for device implantation, per case fluoroscopy time, air kerma, and patient factors, including body mass index. Between-group comparisons were conducted to evaluate RE by group and measurement sites. The Protego system reduced operator RE by 99% compared to that using standard protection. RE was significantly lower at both the thyroid level (0.08 ± 0.27 vs 79.2 ± 62.4 μSv; < .001) and the waist level (0.70 ± 1.50 vs 162.0 ± 91.0 μSv, < .001). "Zero" total RE was documented by RaySafe in 60% (n = 15) of TAVR cases using Protego. In contrast, standard protection did not achieve zero exposure in a single case. The Protego shield system provides superior operator RE protection during TAVR procedures. This shield allows operators to work without the need for personal lead aprons and has potential to reduce catheterization laboratory occupational health hazards.